Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blank Bio is a private healthcare AI and bioinformatics company building RNA foundation models for precision medicine and drug development. The company focuses on extracting clinically relevant information from tumor transcriptomes and bulk RNA-seq data, including isoform, mutation, and expression signals that conventional gene-level analyses may miss. Its products are positioned to support biomarker discovery, patient stratification, clinical trial design, diagnostic accuracy, and therapeutic development, with an initial focus on oncology. Blank Bio also develops research tools for RNA modeling, including mRNA benchmarking resources, and collaborates with sequencing and biopharma partners to generate higher-resolution RNA datasets. The company appears to be a platform business rather than a therapeutic product developer with named drug candidates in the clinic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blank Bio.